$30,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advocating for medicines to protect pigs from harmful diseases and lower the mortality rate of newborn pigs"
You can find more data on corporate lobbying on Quiver Quantitative.
PAHC Insider Trading Activity
PAHC insiders have traded $PAHC stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $PAHC stock by insiders over the last 6 months:
- JACK BENDHEIM (President and CEO) has made 0 purchases and 50 sales selling 267,800 shares for an estimated $11,327,351.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PAHC Hedge Fund Activity
We have seen 120 institutional investors add shares of PAHC stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 663,611 shares (-97.5%) from their portfolio in Q3 2025, for an estimated $26,849,701
- FMR LLC added 537,958 shares (+902.7%) to their portfolio in Q3 2025, for an estimated $21,765,780
- BRANDES INVESTMENT PARTNERS, LP removed 336,900 shares (-89.8%) from their portfolio in Q3 2025, for an estimated $13,630,974
- MILLENNIUM MANAGEMENT LLC removed 271,310 shares (-94.8%) from their portfolio in Q3 2025, for an estimated $10,977,202
- AMERICAN CENTURY COMPANIES INC removed 227,855 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $9,219,013
- JPMORGAN CHASE & CO added 225,110 shares (+1730.9%) to their portfolio in Q3 2025, for an estimated $9,107,950
- LORD, ABBETT & CO. LLC added 136,264 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,513,241
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
PAHC Analyst Ratings
Wall Street analysts have issued reports on $PAHC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/07/2025
- B of A Securities issued a "Underperform" rating on 08/29/2025
To track analyst ratings and price targets for PAHC, check out Quiver Quantitative's $PAHC forecast page.
PAHC Price Targets
Multiple analysts have issued price targets for $PAHC recently. We have seen 2 analysts offer price targets for $PAHC in the last 6 months, with a median target of $38.5.
Here are some recent targets:
- Ekaterina Knyazkova from JP Morgan set a target price of $50.0 on 11/07/2025
- Derik De Bruin from B of A Securities set a target price of $27.0 on 08/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
